These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

165 related items for PubMed ID: 24035714

  • 1. Multiple myeloma international staging system: "staging" or simply "aging" system?
    Bataille R, Annweiler C, Beauchet O.
    Clin Lymphoma Myeloma Leuk; 2013 Dec; 13(6):635-7. PubMed ID: 24035714
    [Abstract] [Full Text] [Related]

  • 2. Multiple myeloma staging based on the combination of beta-2-microglobulin and albumin: the role of albumin in the model.
    Mihou D, Katodritou E, Zervas K.
    Hematology; 2007 Dec; 12(6):527-31. PubMed ID: 17852450
    [Abstract] [Full Text] [Related]

  • 3. International staging system for multiple myeloma.
    Greipp PR, San Miguel J, Durie BG, Crowley JJ, Barlogie B, Bladé J, Boccadoro M, Child JA, Avet-Loiseau H, Kyle RA, Lahuerta JJ, Ludwig H, Morgan G, Powles R, Shimizu K, Shustik C, Sonneveld P, Tosi P, Turesson I, Westin J.
    J Clin Oncol; 2005 May 20; 23(15):3412-20. PubMed ID: 15809451
    [Abstract] [Full Text] [Related]

  • 4. Incorporation of the bone marker carboxy-terminal telopeptide of type-1 collagen improves prognostic information of the International Staging System in newly diagnosed symptomatic multiple myeloma.
    Jakob C, Sterz J, Liebisch P, Mieth M, Rademacher J, Goerke A, Heider U, Fleissner C, Kaiser M, von Metzler I, Müller C, Sezer O.
    Leukemia; 2008 Sep 20; 22(9):1767-72. PubMed ID: 18580957
    [Abstract] [Full Text] [Related]

  • 5. Staging multiple myeloma patients with active disease using serum levels of beta2m-free HLA class I heavy chain together with IgM or platelet count.
    Perosa F, Minoia C, Favoino E, Prete M, Dammacco F.
    Blood Cells Mol Dis; 2009 Sep 20; 42(1):71-6. PubMed ID: 18996035
    [Abstract] [Full Text] [Related]

  • 6. [Classification, staging and prognostic indices for multiple myeloma].
    Hotta T.
    Nihon Rinsho; 2007 Dec 20; 65(12):2161-6. PubMed ID: 18069256
    [Abstract] [Full Text] [Related]

  • 7. [Prognositic factors in multiple myeloma].
    Nagura E.
    Nihon Rinsho; 2007 Dec 20; 65(12):2351-6. PubMed ID: 18069282
    [Abstract] [Full Text] [Related]

  • 8. [Prognostic analysis and assessment on the clinical staging systems of multiple myeloma--a report of 206 cases].
    Tao ZF, Fu WJ, Chen YB, Yuan ZG, Wang DX, Hou J.
    Ai Zheng; 2006 Apr 20; 25(4):461-4. PubMed ID: 16613681
    [Abstract] [Full Text] [Related]

  • 9. Staging systems and prognostic factors as a guide to therapeutic decisions in multiple myeloma.
    Kyrtsonis MC, Maltezas D, Tzenou T, Koulieris E, Bradwell AR.
    Semin Hematol; 2009 Apr 20; 46(2):110-7. PubMed ID: 19389494
    [Abstract] [Full Text] [Related]

  • 10. International prognostic index (IPI)--a critical comparison with five multiple myeloma staging systems in the group of 270 patients treated by conventional chemotherapy.
    Scudla V, Zemanova M, Minarik J, Bacovsky J, Ordeltova M, Indrak K, Budikova M, Dusek L, Farbiakova V.
    Neoplasma; 2006 Apr 20; 53(4):277-84. PubMed ID: 16830053
    [Abstract] [Full Text] [Related]

  • 11. International Staging System required standardization of biochemical laboratory testing in multiple myeloma.
    Tichý M, Maisnar V, Palicka V, Friedecký B, Vávrová J, Novotná H, Cermáková Z, Dastych M, Cechák P, Vogtová D, Jarolímková E, Benáková H, Hachová L, Bezdícková D, Kouril F, Zábranská EA, Zenková J, Slabý P, Scudla V, Gregora E, Spicka I, Straub J, Schützova M, Hájek R.
    Neoplasma; 2006 Apr 20; 53(6):492-4. PubMed ID: 17167717
    [Abstract] [Full Text] [Related]

  • 12. [Analysis of the international staging system of multiple myeloma and its comparison with the DS and IFM staging system in 122 Chinese patients].
    Deng SH, Xu Y, Mai YJ, Wang YF, Zhao YZ, Zou DH, Qiu LG.
    Zhonghua Xue Ye Xue Za Zhi; 2008 Apr 20; 29(4):217-21. PubMed ID: 18843972
    [Abstract] [Full Text] [Related]

  • 13. Stratification of multiple myeloma according to serum beta 2-microglobulin and serum albumin levels.
    Scudla V, Budíková M, Fischerová E, Zadrazil J, Indrák K.
    Acta Univ Palacki Olomuc Fac Med; 1991 Apr 20; 130():201-12. PubMed ID: 1838869
    [Abstract] [Full Text] [Related]

  • 14. Chronic kidney disease stage 5 as the prognostic complement of International Staging System for multiple myeloma.
    Hsiao LT, Yang CF, Yang SH, Gau JP, Yu YB, Hong YC, Liu CY, Liu JH, Chen PM, Chiou TJ, Tzeng CH.
    Eur J Haematol; 2012 Feb 20; 88(2):159-66. PubMed ID: 21973045
    [Abstract] [Full Text] [Related]

  • 15. The international St-aging system as a prognostic marker in general senior population: Findings from the EPIDOS cohort study.
    Pouzoullic M, Schott AM, Sánchez-Rodríguez D, Bataille R, Annweiler C, SOCOS group.
    Eur J Intern Med; 2019 Oct 20; 68():51-54. PubMed ID: 31387843
    [Abstract] [Full Text] [Related]

  • 16. Prognostic factors and staging systems of multiple myeloma:
    Tao ZF, Fu WJ, Yuan ZG, Wang DX, Chen YB, Hou J.
    Chin Med J (Engl); 2007 Oct 05; 120(19):1655-8. PubMed ID: 17935664
    [Abstract] [Full Text] [Related]

  • 17. [Prognostic importance of beta-2-microglobulin in multiple myeloma].
    Avilés A, Zepeda G, Guzmán R, Talavera A, García EL, Díaz-Maqueo JC.
    Rev Invest Clin; 1992 Oct 05; 44(2):215-20. PubMed ID: 1439309
    [Abstract] [Full Text] [Related]

  • 18. Tumor load in patients with multiple myeloma: β2-microglobulin levels versus whole-body MRI.
    D'Anastasi M, Notohamiprodjo M, Schmidt GP, Dürr HR, Reiser MF, Baur-Melnyk A.
    AJR Am J Roentgenol; 2014 Oct 05; 203(4):854-62. PubMed ID: 25247952
    [Abstract] [Full Text] [Related]

  • 19. [Prognostic value of serum beta2-microglobulin in multiple myeloma].
    Bettini R, Redaelli S, Maino C, Bertuol S, Costantini C, Lazzarini A, Brivio L, Gorini M.
    Recenti Prog Med; 2005 Feb 05; 96(2):81-6. PubMed ID: 15844767
    [Abstract] [Full Text] [Related]

  • 20. Plasma cell growth fraction using Ki-67 antigen expression identifies a subgroup of multiple myeloma patients displaying short survival within the ISS stage I.
    Gastinne T, Leleu X, Duhamel A, Moreau AS, Franck G, Andrieux J, Lai JL, Coiteux V, Yakoub-Agha I, Bauters F, Harousseau JL, Zandecki M, Facon T, Intergroupe Francophone du Myelome (IFM).
    Eur J Haematol; 2007 Oct 05; 79(4):297-304. PubMed ID: 17692103
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.